Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
Portuguese (Brazilian)

Clinical Study Results

  • BIWH 3 - Peripheral Arterial Disease
    Clinical Study Number 1181.1
    Study Indication Peripheral Arterial Disease
    Product BIWH 3
    Generic Name BIWH 3
    Lab Code
    Clinical Phase I
    Study Title

    A randomised, double-blind, placebo-controlled, dose escalation study to investigate safety, pharmacokinetics and pharmacodynamics of different doses (0.2, 0.6, 2.0, 6.0, and 20.0 µg/hr) of BIWH 3 administered for 6 hours in patients with chronic Critical Limb Ischaemia (CLI, Fontaine class III or IV). COINART-1 trial (first COllateral INto ARTery Trial)

    Study Document
    Trial synopsis 1181.1_CO english